Keyphrases
Archimedean Copula Models
89%
Breast Cancer
63%
Breast Cancer Susceptibility Gene 1 (BRCA1)
61%
Bivariate
58%
Copula Model
51%
Censored Data
47%
IRF1
46%
Tumor
43%
Bivariate Data
39%
Frailty Model
35%
Gemcitabine
34%
Simulation Study
34%
Phosphoinositide 3-kinase (PI3K)
32%
Right Censoring
32%
Estrogen Receptor 1 (ESR1)
30%
Polyphenon E
30%
Hormone Receptor-negative Breast Cancer
30%
Hepatocellular Carcinoma
30%
Archimedean Copula
30%
Opioid Prescribing
30%
Trauma Patients
30%
Parkinson's Disease
30%
NKX3.1
30%
Goodness-of-fit Test
28%
MicroRNA
25%
Opioids
24%
Kendall Distribution
23%
Tumor Proliferation
23%
PI3K-Akt Pathway
23%
Breast Tumor
22%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
22%
Cell Proliferation
22%
Genotype
21%
Clayton Copula
20%
Competing Risks Data
20%
Marginal Survival Functions
20%
Protein Expression
19%
Green Tea Extract
19%
Breast Cancer Risk
19%
Human Epidermal Growth Factor Receptor 2 (HER2)
19%
Antiangiogenic Therapy
19%
Newly Diagnosed
19%
DNA Damage
18%
Microarray Analysis
18%
Estradiol
18%
Progesterone Receptor
18%
Failure Time
17%
Pancreatic Cancer Cells
17%
Tissue Microarray
17%
Growth Factors
17%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
53%
Cancer Cell
46%
Biological Marker
35%
Estrogen Receptor Alpha
30%
Polyphenon E
30%
Hormone Receptor
30%
Opiate
30%
Injury
30%
Placebo
26%
microRNA
26%
Breast Tumor
23%
Bevacizumab
23%
Sinecatechins
19%
Antiangiogenic Therapy
17%
Gene Expression
17%
Lung Cancer
17%
Cell Line
16%
Tissue Microarray
16%
Breast Cancer Cell Line
15%
Triple Negative Breast Cancer
15%
Wilms' Tumor
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Thymidylate Synthase
15%
Adenosquamous Carcinoma
15%
Proteomics
15%
Fluorouracil
15%
X Box Binding Protein 1
15%
Immunoglobulin Enhancer Binding Protein
15%
Alpha Adrenergic Receptor
15%
Interferon Regulatory Factor 1
15%
Receptor Protein
15%
Nucleophosmin
15%
Progesterone Receptor
15%
Gemcitabine
15%
Optical Tomography
15%
Triamcinolone
15%
Keloid
15%
Circulating microRNA
15%
Hepatocellular Carcinoma
15%
Levetiracetam
15%
Post-Traumatic Seizure
15%
Overall Survival
15%
Hepatectomy
15%
Histone Deacetylase
15%
Prostaglandin Synthase
15%
Patient-Reported Outcome
15%
Neurotoxicity
15%
Paresthesia
15%
Paclitaxel
15%
